LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript February 27, 2025LeMaitre Vascular, Inc. reports earnings inline with expectations.
Lemaitre Vascular Inc (LMAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ranger Investment Management Conrad Doenges (Cio) | 658,229 | $60,649,220 | 3.82% | |
| 2. | Driehaus Capital Richard Driehaus | 263,220 | $24,253,091 | -2% | 0.2% |
| 3. | Renaissance Technologies Jim Simons | 163,800 | $15,092,532 | +1% | 0.02% |
| 4. | Millennium Management Israel Englander | 96,081 | $8,852,903 | +97% | 0% |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 66,173 | $6,097,180 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.06 | 30 | Director | 181 | 2020-08-26 | Filing | |
| $25.28 | 151 | Director | 151 | 2020-05-21 | Filing | |
| $28.35 | 7,074 | Officer, Director | 43,557 | 2020-08-14 | Filing | |
| $5.50 | 4,000 | Large Shareholder, Officer, Director | 3,927,163 | 2012-06-08 | Filing | |
| $5.34 | 2,000 | Large Shareholder, Officer, Director | 3,917,163 | 2012-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.00 | 3,142 | Director | 2,607 | 2025-03-04 | Filing | |
| $103.50 | 198 | Director | 5,111 | 2024-11-20 | Filing | |
| $101.47 | 3,750 | Director | 2,278 | 2024-11-15 | Filing | |
| $103.38 | 396 | Director | 1,304 | 2024-11-13 | Filing | |
| $103.37 | 1,070 | Director | 1,700 | 2024-11-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,913,832 | $360,620,483 | 0% | |
| 2. | 1,692,834 | $155,977,679 | 2.06% | |
| 3. | 1,580,117 | $145,591,980 | 0% | |
| 4. | 1,172,015 | $107,989,557 | 2% | |
| 5. | 865,582 | $79,754,759 | 1.38% |
News See All
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q2 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Welcome to the LeMaitre Vascular First Quarter 2024 Financial Results Conference Call. As a reminder, today’s call is being recorded.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker’s presentation, there will be a question-and-answer session.
Here’s Why LeMaitre Vascular (LMAT) Outperformed in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
Billionaire Hedge Funds
